
KALV’s latest rating updates from top analysts.
KalVista Pharmaceuticals Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1 million
KalVista Pharmaceuticals Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, KalVista Pharmaceuticals Inc revealed its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
KalVista Pharmaceuticals Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its